Molnupiravir and Favipiravir in the therapeutics of SARS-CoV-2 - A review. Indian J Pharm Drug Studies. 2023;1(3):73-78. Accessed May 7, 2024. https://mansapublishers.com/index.php/ijpds/article/view/3575